| Kaitlyn Nicole Welch, | |
|
2802 W Walker St, Breckenridge, TX 76424-4000 | |
| (254) 559-7215 | |
| Not Available |
| Full Name | Kaitlyn Nicole Welch |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 2802 W Walker St, Breckenridge, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124755905 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 1089089 (Texas) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 1089089 (Texas) | Primary |
| Entity Name | Shackelford County Community Resource Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194804278 PECOS PAC ID: 8628027174 Enrollment ID: O20050121000572 |
News Archive
Hamamatsu Photonics K.K. is pleased to announce that is has been awarded Reissue Patent No. 42,220, confirming the patentability of its original Patent 6,847,729, a pioneering patent directed to slide scanning with remote viewing.
Sedentary older adults with no genetic risk factors for dementia may be just as likely to develop the disease as those who are genetically predisposed, according to a major study which followed more than 1,600 Canadians over five years.
The capacity for memory isn't exclusive to the brain. The immune system, with its sprawling network of diverse cell types, can recall the pathogens it meets, helping it to swiftly neutralize those intruders upon future encounters.
Aestus Therapeutics, Inc. and Prosidion Ltd., a wholly owned subsidiary of Astellas Pharma Inc., announced today a license agreement providing Aestus with exclusive, world-wide rights to the Prosidion investigational product PSN-357.
› Verified 3 days ago
| Entity Name | Dcs Medical Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285082768 PECOS PAC ID: 0042507600 Enrollment ID: O20160926000390 |
News Archive
Hamamatsu Photonics K.K. is pleased to announce that is has been awarded Reissue Patent No. 42,220, confirming the patentability of its original Patent 6,847,729, a pioneering patent directed to slide scanning with remote viewing.
Sedentary older adults with no genetic risk factors for dementia may be just as likely to develop the disease as those who are genetically predisposed, according to a major study which followed more than 1,600 Canadians over five years.
The capacity for memory isn't exclusive to the brain. The immune system, with its sprawling network of diverse cell types, can recall the pathogens it meets, helping it to swiftly neutralize those intruders upon future encounters.
Aestus Therapeutics, Inc. and Prosidion Ltd., a wholly owned subsidiary of Astellas Pharma Inc., announced today a license agreement providing Aestus with exclusive, world-wide rights to the Prosidion investigational product PSN-357.
› Verified 3 days ago
| Entity Name | Qv Urgent Care Tx Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568098887 PECOS PAC ID: 5395176267 Enrollment ID: O20200508000781 |
News Archive
Hamamatsu Photonics K.K. is pleased to announce that is has been awarded Reissue Patent No. 42,220, confirming the patentability of its original Patent 6,847,729, a pioneering patent directed to slide scanning with remote viewing.
Sedentary older adults with no genetic risk factors for dementia may be just as likely to develop the disease as those who are genetically predisposed, according to a major study which followed more than 1,600 Canadians over five years.
The capacity for memory isn't exclusive to the brain. The immune system, with its sprawling network of diverse cell types, can recall the pathogens it meets, helping it to swiftly neutralize those intruders upon future encounters.
Aestus Therapeutics, Inc. and Prosidion Ltd., a wholly owned subsidiary of Astellas Pharma Inc., announced today a license agreement providing Aestus with exclusive, world-wide rights to the Prosidion investigational product PSN-357.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kaitlyn Nicole Welch, 2802 W Walker St, Breckenridge, TX 76424-4000 Ph: (254) 559-7215 | Kaitlyn Nicole Welch, 2802 W Walker St, Breckenridge, TX 76424-4000 Ph: (254) 559-7215 |
News Archive
Hamamatsu Photonics K.K. is pleased to announce that is has been awarded Reissue Patent No. 42,220, confirming the patentability of its original Patent 6,847,729, a pioneering patent directed to slide scanning with remote viewing.
Sedentary older adults with no genetic risk factors for dementia may be just as likely to develop the disease as those who are genetically predisposed, according to a major study which followed more than 1,600 Canadians over five years.
The capacity for memory isn't exclusive to the brain. The immune system, with its sprawling network of diverse cell types, can recall the pathogens it meets, helping it to swiftly neutralize those intruders upon future encounters.
Aestus Therapeutics, Inc. and Prosidion Ltd., a wholly owned subsidiary of Astellas Pharma Inc., announced today a license agreement providing Aestus with exclusive, world-wide rights to the Prosidion investigational product PSN-357.
› Verified 3 days ago